Peripheral Arterial Disease Trial, Recruiting (NCT03663777)

Peripheral Arterial Disease Trial, Recruiting NCT03663777 Sponsor: University of Nove de Julho Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT03663777 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a woman who has gone through menopause and are not currently taking hormone replacement therapy
A test measuring blood flow from your heart to your ankles shows a result below 0.90 (this is called an ankle-brachial index test — confirm with trial site if unsure)
Your body mass index (a measure of body weight relative to height) is below 35 kg/m²
You have not had any limb amputations
Your blood pressure is below 160 (top number) and below 105 (bottom number)

Who may not be able to join:

You change or adjust any of your medications during the study period before the programme is finished
You develop a health problem during the study that stops you from being able to do physical activity

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Raphael Dias, PhD, University of Nove de Julho

Phone: +5519999406878

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03663777

Sponsor: University of Nove de Julho

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: +5519999406878

More information: https://clinicaltrials.gov/study/NCT03663777

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a woman who has gone through menopause and are not currently taking hormone replacement therapy
A test measuring blood flow from your heart to your ankles shows a result below 0.90 (this is called an ankle-brachial index test — confirm with trial site if unsure)
Your body mass index (a measure of body weight relative to height) is below 35 kg/m²
You have not had any limb amputations
Your blood pressure is below 160 (top number) and below 105 (bottom number)

Who may not be able to join:

You change or adjust any of your medications during the study period before the programme is finished
You develop a health problem during the study that stops you from being able to do physical activity

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Nove de Julho

Registry

ClinicalTrials.gov

Start date

1 August 2018

Est. completion

30 December 2027

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Change from baseline in blood pressure at 12 weeks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov